Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mona Lichtblau

Showing results (1-10 of 156) with videos related to

Pageof 16
Sort By:
Pulmonary Circulation|August 13, 2020
The course of COVID-19 in a 55-year-old patient diagnosed with severe idiopathic pulmonary arterial hypertensionDiana Mandler, Mona Lichtblau, Silvia Ulrich
Pulmonary Circulation|June 27, 2024
Pulmonary vascular disease, environmental pollution, and climate changeMona Lichtblau, Lena Reimann, Lucilla Piccari
European Heart Journal. Case Reports|October 18, 2023
An unexpected cause of pulmonary hypertension in a young woman: a case reportJudith Aeberhard, Mona Lichtblau, Nisha Arenja
Praxis|February 7, 2019
[Obstructive Sleep Apnea Syndrome]Anne-Christin Stöwhas, Mona Lichtblau, Konrad E Bloch
Praxis|January 4, 2023
[Pulmonary Endarterectomy and Treatment for Chronic Thromboembolic Pulmonary Hypertension]Linus Dubs, Silvia Ulrich, Mona Lichtblau, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 20, 2023
Clinical-radiological-pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanismsMona Lichtblau, Laura Mayer, Deepa Gopalan, et al.
European Journal of Internal Medicine|September 6, 2023
What changed after the 2022 guidelines for pulmonary hypertension?Mona Lichtblau, Anna Titz, Barbara Bahrampoori, et al.
Therapeutische Umschau. Revue Therapeutique|January 22, 2026
[Acute high-altitude illnesses - Definition, Prophylaxis, Therapy]Dinah Hertig, Mona Lichtblau, Michael Furian, et al.
Breathe (Sheffield, England)|March 3, 2023
Balloon pulmonary angioplasty: are we there yet? Lessons learned and unanswered questionsMitja Jevnikar, Aleksandar Bokan, Thomas Gille, et al.
Lung|April 10, 2019
Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective AnalysisCharlotte Berlier, Esther I Schwarz, Stéphanie Saxer, et al.
Pageof 16

Showing results (1-10 of 156) with videos related to

Sort By:
Pageof 16
Pulmonary Circulation|August 13, 2020
The course of COVID-19 in a 55-year-old patient diagnosed with severe idiopathic pulmonary arterial hypertensionDiana Mandler, Mona Lichtblau, Silvia Ulrich
Pulmonary Circulation|June 27, 2024
Pulmonary vascular disease, environmental pollution, and climate changeMona Lichtblau, Lena Reimann, Lucilla Piccari
European Heart Journal. Case Reports|October 18, 2023
An unexpected cause of pulmonary hypertension in a young woman: a case reportJudith Aeberhard, Mona Lichtblau, Nisha Arenja
Praxis|February 7, 2019
[Obstructive Sleep Apnea Syndrome]Anne-Christin Stöwhas, Mona Lichtblau, Konrad E Bloch
Praxis|January 4, 2023
[Pulmonary Endarterectomy and Treatment for Chronic Thromboembolic Pulmonary Hypertension]Linus Dubs, Silvia Ulrich, Mona Lichtblau, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|December 20, 2023
Clinical-radiological-pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanismsMona Lichtblau, Laura Mayer, Deepa Gopalan, et al.
European Journal of Internal Medicine|September 6, 2023
What changed after the 2022 guidelines for pulmonary hypertension?Mona Lichtblau, Anna Titz, Barbara Bahrampoori, et al.
Therapeutische Umschau. Revue Therapeutique|January 22, 2026
[Acute high-altitude illnesses - Definition, Prophylaxis, Therapy]Dinah Hertig, Mona Lichtblau, Michael Furian, et al.
Breathe (Sheffield, England)|March 3, 2023
Balloon pulmonary angioplasty: are we there yet? Lessons learned and unanswered questionsMitja Jevnikar, Aleksandar Bokan, Thomas Gille, et al.
Lung|April 10, 2019
Real-Life Experience with Selexipag as an Add-On Therapy to Oral Combination Therapy in Patients with Pulmonary Arterial or Distal Chronic Thromboembolic Pulmonary Hypertension: A Retrospective AnalysisCharlotte Berlier, Esther I Schwarz, Stéphanie Saxer, et al.
Pageof 16